PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
46.92
ESG score below 80% of RNAZ's 63.21. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
27.98
Environmental score below 80% of RNAZ's 55.41. Jim Chanos would check for potential stranded asset risks and carbon liabilities.
55.48
Social score 80-90% of RNAZ's 67.22. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
57.30
Governance score 80-90% of RNAZ's 67.01. Walter Schloss would scrutinize management accountability and board independence.